Heart, Lung and Circulation

Titration of medications by HF nurses increases optimisation doses of key therapeutic agents

      Background: Chronic heart failure (CHF) has a high mortality and morbidity. Large scale RCTs have proven the benefits of beta blockade (BB) and ACE inhibitors (ACEI) in reducing mortality in patients with CHF and expert guidelines mandate their use. In spite of these recommendations, important therapies are under-prescribed and under-utilised.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect